Series date: 
08/02/2024 - 3:00pm CDT to 06/27/2025 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Quarterly


Series Director

Eva Clark, MD, PhD, CTropMed

Series Co-Director

Jill Weatherhead, MD, PhD, CTropMed

Series Co-Director

Jeffrey D. Whitman, MD


Target Audience and Needs

Clinicians in the United States, public health workers, and healthcare students and trainees do not receive systematic training about Chagas disease, even though a large portion of the U.S. population is at risk, including immigrants from continental Latin America and people living in the Southern United States where the Triatomine vector is endemic.  At-risk children, women of reproductive age, and immunocompromised individuals particularly should be screened for the disease, and those confirmed to be positive should be treated to reduce their risk of developing severe sequelae of Chagas disease.  This case conference aims to advance learner knowledge about the evidence-based recommendations for Chagas disease diagnosis, management, monitoring of treatment side effects, and implementation of strategies for screening and prevention.  The overall goals are to enhance the quality of care for patients with Chagas disease in the United States and to improve patient outcomes by reducing disease-related morbidity and mortality.


Educational Methods

Educational methods will include lectures, case presentations, and panel discussion.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss the epidemiology and transmission of Chagas disease, its known risk factors, and its classical clinical manifestations.
  • Apply guideline-based strategies to screen for and diagnose Chagas disease.
  • Use public health tools to identify U.S. populations most at risk for Chagas disease and its sequelae.
  • Implement effective treatment regimens and recognize their common side effects.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 
Eva Clark, MD, PhD, CTropMed
eva.clark@bcm.edu
(256) 683-2943
Series location: 
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
United States

Sessions

There are no sessions in this series.